The Cystic Fibrosis Foundation (CFF) is a leading non-profit organization dedicated to curing cystic fibrosis (CF) and providing all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment, and ensuring access to high-quality, specialized care. They have been instrumental in advancing CF research and treatment, significantly extending the lifespan and improving the quality of life for people with CF. The Foundation operates on a venture philanthropy model, investing donor funds into research programs and biotechnology companies to accelerate the development of new therapies.
The headquarters serves as the central hub for strategic planning, research funding allocation, national advocacy efforts, patient support program coordination, and administrative operations for the entire organization.
Modern office facilities designed to support a collaborative and mission-focused workforce. Its location in the Washington D.C. metropolitan area provides proximity to key governmental health organizations and research institutions.
A highly mission-driven and passionate work environment. Employees are deeply committed to the cause of finding a cure for CF and supporting the CF community. The culture emphasizes collaboration, innovation, and patient-centricity.
The Bethesda headquarters is pivotal for orchestrating the Foundation's national and international efforts, managing substantial research investments, and driving policy changes that benefit individuals with cystic fibrosis.
While the Cystic Fibrosis Foundation is primarily U.S.-based with its operational headquarters and chapter network within the United States, its impact is global. The CFF funds research internationally, collaborates with global CF organizations, researchers, and clinicians, and participates in international consortia to share knowledge, advance scientific understanding, and accelerate the development of therapies for cystic fibrosis worldwide. They support a global network of care centers and clinical trial sites.
4550 Montgomery Avenue, Suite 1100 N
Bethesda
Maryland
USA
Address: Varies by chapter (numerous local offices across the United States). Example: Greater Illinois Chapter, 150 N. Michigan Ave., Suite 1550, Chicago, IL 60601.
To implement the Foundation's mission at a local level, tailoring national programs to meet community needs, building local partnerships, and fostering a supportive network for individuals and families affected by CF.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cystic Fibrosis Foundation' leadership includes:
Cystic Fibrosis Foundation has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major high-profile executive leadership (President/CEO, EVP) changes publicly announced in the last 12 months. The leadership team has shown stability.
Discover the tools Cystic Fibrosis Foundation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The Cystic Fibrosis Foundation likely uses standard professional email formats, commonly incorporating the employee's first initial and last name, or full name.
[first_initial][last]@cff.org
Format
mboyle@cff.org
Example
80%
Success rate
cff.org • June 4, 2024
The Cystic Fibrosis Foundation issued a statement regarding the FDA advisory committee meeting discussing Vertex Pharmaceuticals' triple combination therapy (elexacaftor/tezacaftor/ivacaftor) for children ages 2-5 with certain CF mutations. The Foundation highlighted the urgent need for approved therapies for young children....more
cff.org • May 21, 2024
The Cystic Fibrosis Foundation announced a $9.5 million investment through its Therapeutic Development Awards program to support seven new research projects aimed at developing novel treatments for cystic fibrosis, focusing on areas such as infection, inflammation, and addressing the underlying cause of CF for all individuals with the disease....more
cff.org • February 27, 2024
The CFF launched a $15 million initiative, 'Advancing Research for Rare CF Mutations,' to accelerate the development of treatments for individuals with rare cystic fibrosis mutations who do not yet have highly effective modulator therapies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cystic Fibrosis Foundation, are just a search away.